GPT and Decreased total neutrophil count: The most common patient grade 3/4 adverse events were noncumulative neutropenia (41.9%) and transient asymptomatic transaminase increases of ALT and AST observed in 43.5% and 30.6% of patients, respectively, without symptoms of hepatic failure.